Restricted accessReview articleFirst published online 2026-3
Probiotics and aging: Impacts on cognitive function,brain-derived neurotrophic factor,inflammation,and antioxidant activity. A systematic review and meta-analysis
Cognitive decline represents a major challenge in aging populations. Probiotics have been proposed to influence cognitive function through gut–brain interactions, but clinical findings remain inconsistent.
Objective
This study evaluated the effects of probiotic supplementation on cognitive function as the primary outcome, and on BDNF levels, inflammatory markers, and oxidative stress biomarkers as secondary outcomes in adults aged 50 years and older.
Methods
A systematic search of PubMed, EBSCO, ProQuest, and Google Scholar was conducted through 1 May 2024 using predefined search terms related to probiotics, cognitive function, BDNF, inflammation, and antioxidant activity. Study quality was assessed using the RoB 2 tool. Meta-analyses were performed using random-effects models, and publication bias was explored using Egger's test where study counts permitted.
Results
Sixteen studies demonstrated significant improvement in cognitive function among participants receiving probiotics compared to placebo. Cognitive function, measured using the Mini-Mental State Examination (MMSE), yielded a standardized mean difference (SMD) of 0.747 (95% CI 0.307–1.186) which corresponds to moderate-to-large effects. In comparison, the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) showed significant results with an SMD of 0.340 (95% CI 0.032–1.366) which corresponds to small-to-moderate effects. Probiotics also led to significant changes in several biochemical parameters, including BDNF, TNF-α, 8-OHdG, IL-6, IL-10, MDA, TAC, and GSH. Multi-strain probiotics showed better results compared to single-strain.
Conclusions
Probiotic supplementation may offer modest cognitive benefits in aging populations, particularly in studies enrolling cognitively impaired individuals, but substantial heterogeneity and limited biomarker evidence restrict the certainty of these findings. Larger, longer-duration, and standardized trials are needed to clarify the clinical relevance and potential biological pathways underlying probiotic effects on cognition.
BaierleMNascimentoSNMoroAM, et al.Relationship between inflammation and oxidative stress and cognitive decline in the institutionalized elderly. Oxid Med Cell Longev2015; 2015: 804198.
2.
WuZYuJZhuA, et al.Nutrients, microglia aging, and brain aging. Oxid Med Cell Longev2016; 2016: 7498528.
3.
Tangestani FardMStoughC. A review and hypothesized model of the mechanisms that underpin the relationship between inflammation and cognition in the elderly. Front Aging Neurosci2019; 11: 00056.
4.
NicholsEVosT. The estimation of the global prevalence of dementia from 1990-2019 and forecasted prevalence through 2050: an analysis for the Global Burden of Disease (GBD) study 2019. Alzheimers Dement2021; 17: e051496.
5.
Tahami MonfaredAAByrnesMJWhiteLA, et al.Alzheimer’s disease: epidemiology and clinical progression. Neurol Ther2022; 11: 553–569.
6.
MayerEANanceKChenS. The gut-brain axis. Annu Rev Med2022; 73: 439–453.
7.
MargolisKGCryanJFMayerEA. The microbiota-gut-brain axis: from motility to mood. Gastroenterology2021; 160: 1486–1501.
8.
Colucci-D’AmatoLSperanzaLVolpicelliF. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci2020; 21: 7777.
9.
WangCSKavalaliETMonteggiaLM. BDNF Signaling in context: from synaptic regulation to psychiatric disorders. Cell2022; 185: 62–76.
10.
NgTKSHoCSHTamWWS, et al.Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer’s disease (AD): a systematic review and meta-analysis. Int J Mol Sci2019; 20: 257.
11.
GravesteijnEMensinkRPPlatJ. Effects of nutritional interventions on BDNF concentrations in humans: a systematic review. Nutr Neurosci2022; 25: 1425–1436.
12.
ChenMWangYDengS, et al.Skeletal muscle oxidative stress and inflammation in aging: focus on antioxidant and anti-inflammatory therapy. Front Cell Dev Biol2022; 10: 964130.
13.
SantoroAMartucciMConteM, et al.Inflammaging, hormesis and the rationale for anti-aging strategies. Ageing Res Rev2020; 64: 101142.
14.
BrodackiBStaszewskiJToczyłowskaB, et al.Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism. Neurosci Lett2008; 441: 158–162.
15.
TegelerCO’SullivanJLBucholtzN, et al.The inflammatory markers CRP, IL-6, and IL-10 are associated with cognitive function—data from the Berlin Aging Study II. Neurobiol Aging2016; 38: 112–117.
16.
FracassiAMarcattiMZolochevskaO, et al.Oxidative damage and antioxidant response in frontal cortex of demented and nondemented individuals with Alzheimer’s neuropathology. J Neurosci2021; 41: 538–554.
17.
LiuJSunSChenY. Superoxide dismutase modified the association of serum malondialdehyde levels with cognitive decline among older adults: findings from the Chinese Longitudinal Healthy Longevity Survey. J Alzheimers Dis2024; 99: 657–665.
18.
CristoforiFDargenioVNDargenioC, et al.Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol2021; 12: 578386.
19.
LiXHuDTianY, et al.Protective effects of a novel Lactobacillus rhamnosus strain with probiotic characteristics against lipopolysaccharide-induced intestinal inflammation in vitro and in vivo. Food Funct2020; 11: 5799–5814.
20.
LeeJHwangKTChungMY, et al.Resistance of Lactobacillus casei KCTC 3260 to reactive oxygen species (ROS): role for a metal ion chelating effect. J Food Sci2005; 70: m388–m391.
21.
SunJHuXLLeGW, et al.Lactobacilli prevent hydroxy radical production and inhibit Escherichia coli and Enterococcus growth in system mimicking colon fermentation. Lett Appl Microbiol2010; 50: 264–269.
22.
AgahiAHamidiGADaneshvarR, et al.Does severity of Alzheimer’s Disease contribute to its responsiveness to modifying gut microbiota? A double blind clinical trial. Front Neurol2018; 9: 00662.
23.
AkbariEAsemiZDaneshvar KakhakiR, et al.Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci2016; 8: 00256.
24.
AkhgarjandCVahabiZShab-BidarS, et al.Effects of probiotic supplements on cognition, anxiety, and physical activity in subjects with mild and moderate Alzheimer’s disease: a randomized, double-blind, and placebo-controlled study. Front Aging Neurosci2022; 14: 1032494.
25.
AkhgarjandCVahabiZShab-BidarS, et al.The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled study. Inflammopharmacology2024; 32: 1413–1420.
26.
AsaokaDXiaoJTakedaT, et al.Effect of probiotic Bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: results of a 24-week randomized, double-blind, placebo-controlled trial. J Alzheimers Dis2022; 88: 75–95.
27.
ChungYCJinHMCuiY, et al.Fermented milk of Lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J Funct Foods2014; 10: 465–474.
28.
FeiYWangRLuJ, et al.Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment. Geriatr Nurs2023; 51: 167–175.
29.
HandajaniYSTuranaYYogiaraY, et al.Effects of tempeh probiotics on elderly with cognitive impairment. Front Aging Neurosci2022; 14: 891773.
30.
HsuYCHuangYYTsaiSY, et al.Efficacy of Probiotic supplements on brain-derived neurotrophic factor, inflammatory biomarkers, oxidative stress and cognitive function in patients with Alzheimer’s Dementia: a 12-week randomized, double-blind active-controlled study. Nutrients2023; 16: 16.
31.
HwangYHParkSPaikJW, et al.Efficacy and safety of Lactobacillus plantarum C29-fermented soybean (dw2009) in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial. Nutrients2019; 11: 305.
32.
InoueTKobayashiYMoriN, et al.Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects. Benef Microbes2018; 9: 843–853.
33.
KimCSChaLSimM, et al.Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling older adults: a randomized, double-blind, placebo-controlled, multicenter trial. J Gerontol A Biol Sci Med Sci2021; 76: 32–40.
34.
KobayashiYKuharaTOkiM, et al.Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial. Benef Microbes2019; 10: 511–520.
35.
LouzadaERRibeiroSML. Synbiotic supplementation, systemic inflammation, and symptoms of brain disorders in elders: a secondary study from a randomized clinical trial. Nutr Neurosci2020; 23: 93–100.
36.
SakuraiKToshimitsuTOkadaE, et al.Effects of Lactiplantibacillus plantarum OLL2712 on memory function in older adults with declining memory: a randomized placebo-controlled trial. Nutrients2022; 14: 4300.
37.
SanbornVAzcarate-PerilMAUpdegraffJ, et al.Randomized clinical trial examining the impact of Lactobacillus rhamnosus GG probiotic supplementation on cognitive functioning in middle-aged and older adults. Neuropsychiatr Dis Treat2020; 16: 2765–2777.
38.
ShiSZhangQSangY, et al.Probiotic Bifidobacterium longum BB68S improves cognitive functions in healthy older adults: a randomized, double-blind, placebo-controlled trial. Nutrients2022; 15: 51.
39.
TamtajiORHeidari-SoureshjaniRMirhosseiniN, et al.Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer’s disease: a randomized, double-blind, controlled trial. Clin Nutr2019; 38: 2569–2575.
40.
XiaoJKatsumataNBernierF, et al.Probiotic Bifidobacterium breve in improving cognitive functions of older adults with suspected mild cognitive impairment: a randomized, double-blind, placebo-controlled trial. J Alzheimers Dis2020; 77: 139–147.
41.
HouKWuZXChenXY, et al.Microbiota in health and diseases. Signal Transduct Target Ther2022; 7: 135.
42.
ŚliżewskaKMarkowiak-KopećPŚliżewskaW. The role of probiotics in cancer prevention. Cancers (Basel)2020; 13: 20.
43.
WieërsGBelkhirLEnaudR, et al.How probiotics affect the microbiota. Front Cell Infect Microbiol2020; 9: 00454.
44.
StavropoulouEBezirtzoglouE. Probiotics in medicine: a long debate. Front Immunol2020; 11: 02192.
45.
TarassovaOEkblomMMMobergM, et al.Peripheral BDNF Response to physical and cognitive exercise and its association with cardiorespiratory fitness in healthy older adults. Front Physiol2020; 11: 01080.
46.
RahimlouMHosseiniSAMajdinasabN, et al.Effects of long-term administration of multi-strain probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Nutr Neurosci2022; 25: 411–422.
47.
DehghaniFAbdollahiSShidfarF, et al.Probiotics supplementation and brain-derived neurotrophic factor (BDNF): a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci2023; 26: 942–952.
48.
SchneiderEDollJPKSchweinfurthN, et al.Effect of short-term, high-dose probiotic supplementation on cognition, related brain functions and BDNF in patients with depression: a secondary analysis of a randomized controlled trial. J Psychiatry Neurosci2023; 48: E23–E33.
49.
HsuYCHuangYYTsaiSY, et al.Efficacy of probiotic supplements on brain-derived neurotrophic factor, inflammatory biomarkers, oxidative stress and cognitive function in patients with Alzheimer’s dementia: a 12-week randomized, double-blind active-controlled study. Nutrients2024; 16: 16.
50.
MilajerdiAMousaviSMSadeghiA, et al.The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. Eur J Nutr2020; 59: 633–649.
51.
AghamohammadSSepehrAMiriST, et al.The effects of the probiotic cocktail on modulation of the NF-kB and JAK/STAT signaling pathways involved in the inflammatory response in bowel disease model. BMC Immunol2022; 23: 8.
52.
FriedlandRP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. J Alzheimers Dis2015; 45: 349–362.
53.
ZhuangZQShenLLLiWW, et al.Gut microbiota is altered in patients with Alzheimer’s disease. J Alzheimers Dis2018; 63: 1337–1346.
54.
PetersonCT. Dysfunction of the Microbiota-gut-brain axis in neurodegenerative disease: the promise of therapeutic modulation with prebiotics, medicinal herbs, probiotics, and synbiotics. J Evid-Based Integr Med2020; 25: 2515690X–20957225.
55.
UngerMMSpiegelJDillmannKU, et al.Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord2016; 32: 66–72.
56.
Perez-PardoPKliestTDodiyaHB, et al.The gut-brain axis in Parkinson’s disease: possibilities for food-based therapies. Eur J Pharmacol2017; 817: 86–95.
57.
Hill-BurnsEMDebeliusJWMortonJT, et al.Parkinson’s disease and Parkinson’s disease medications have distinct signatures of the gut microbiome. Mov Disord2017; 32: 739–749.
58.
CattaneoACattaneNGalluzziS, et al.Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging2017; 49: 60–68.
59.
KumarDKVChoiSHWashicoskyKJ, et al.Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med2016; 8: 340ra372.
60.
PorroCCianciulliAPanaroMA. The regulatory role of IL-10 in neurodegenerative diseases. Biomolecules2020; 10: 1017.
61.
D’AnnaLAbu-RumeilehSFabrisM, et al.Serum Interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in Alzheimer disease patients. Neurodegener Dis2017; 17: 227–234.
62.
PetrellaCStrimpakosGTorcinaroA, et al.Proneurogenic and neuroprotective effect of a multi strain probiotic mixture in a mouse model of acute inflammation: involvement of the gut-brain axis. Pharmacol Res2021; 172: 105795.
63.
AbdelhamidMZhouCOhnoK, et al.Probiotic Bifidobacterium breve prevents memory impairment through the reduction of both amyloid-β production and microglia activation in APP knock-in mouse 1. J Alzheimers Dis2022; 85: 1555–1571.
64.
JurcauA. The role of natural antioxidants in the prevention of dementia—where do we stand and future perspectives. Nutrients2021; 13: 282.
65.
KimSLeeJYJeongY, et al.Antioxidant activity and probiotic properties of lactic acid bacteria. Fermentation2022; 8: 29.
66.
FengTWangJ. Oxidative stress tolerance and antioxidant capacity of lactic acid bacteria as probiotic: a systematic review. Gut Microbes2020; 12: 1801944.
67.
FijanSKocbekPSteyerA, et al.The antimicrobial effect of various single-strain and multi-strain probiotics, dietary supplements or other beneficial microbes against common clinical wound pathogens. Microorganisms2022; 10: 2518.
68.
KwojiIDAiyegoroOAOkpekuM, et al.Multi-strain probiotics: synergy among isolates enhances biological activities. Biology (Basel)2021; 10: 322.
69.
McFarlandLV. Efficacy of single-strain probiotics versus multi-strain mixtures: systematic review of strain and disease specificity. Dig Dis Sci2021; 66: 694–704.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
